Hyaluronic acid has become one of the most recognized ingredients in hydration and tissue care. While most consumers associate it with skincare, its properties are increasingly relevant to another important area of women’s health: vaginal dryness and vulvovaginal discomfort.

But there is an important point that is often overlooked.

Not all hyaluronic acid is the same. Molecular weight matters.

At Hudi Pharma, we believe the next generation of vaginal health products will increasingly move beyond simply asking how much hyaluronic acid a formulation contains and start considering which molecular weights are used, how they interact with vaginal tissue and how they can be combined within an optimized delivery system.

Why Hyaluronic Acid for Vaginal Health?

Hyaluronic acid (HA) is a naturally occurring component of the extracellular matrix and plays an important role in tissue hydration, viscoelasticity and tissue homeostasis.

These characteristics make HA particularly interesting for vaginal health, where maintaining adequate hydration and tissue integrity is essential for comfort and quality of life.

Vaginal dryness can occur at different stages of a woman’s life but becomes particularly common during and after menopause. Declining estrogen levels can contribute to changes in the vaginal epithelium and reduced lubrication, potentially leading to dryness, irritation, discomfort and painful intercourse.

For women looking for non-hormonal options, locally administered hyaluronic acid has therefore attracted considerable scientific and clinical interest.

A 2026 systematic review and meta-analysis of randomized controlled trials reported improvements associated with vaginal HA in vaginal dryness-related quality of life, sexual function and vaginal health parameters in postmenopausal women. The authors rated the evidence for vaginal dryness and sexual-function outcomes as moderate, while also emphasizing the need for greater standardization of formulations and longer-term studies. citeturn0search0turn0search2

Molecular Weight Changes the Story

Talking simply about “hyaluronic acid” does not tell the whole story.

HA consists of chains that can vary considerably in molecular size, and these differences can influence its physicochemical and biological behavior.

Scientific literature increasingly recognizes molecular weight as an important parameter when considering HA applications in women’s health. High-molecular-weight HA is generally associated with structural, barrier and anti-inflammatory functions, while lower molecular-weight fractions can display different biological and tissue-interaction characteristics. citeturn0search5turn0search7

This creates an interesting formulation opportunity.

Rather than relying exclusively on one molecular-weight fraction, a multi-molecular-weight approach can be designed to bring together HA fractions with different and potentially complementary functional characteristics.

Why Consider Multi-Molecular-Weight HA?

Think of vaginal hydration as more than simply adding moisture to a surface.

Different molecular-weight fractions can be selected with different formulation objectives in mind.

Higher molecular weights can contribute to surface hydration, film formation and protection, while smaller HA fractions may interact differently with the tissue environment. By combining carefully selected molecular weights, formulators can therefore explore a broader functional profile than when considering HA purely as a single hydration ingredient.

The objective is a more sophisticated approach to vaginal hydration and tissue support, potentially combining:

1. Immediate hydration.
2. Moisture retention.
3. Tissue support.
4. Comfort and elasticity.
5. Prolonged local action.

Importantly, these characteristics should be understood as the scientific and formulation rationale for a multi-molecular-weight strategy rather than evidence that every multi-MW formulation is clinically superior to every single-MW formulation.

The final performance of a vaginal product depends on the complete formulation, HA characteristics and concentration, delivery system, excipients, dosage and treatment protocol.

Growing Evidence for Vaginal Hyaluronic Acid

The scientific evidence supporting vaginal HA continues to develop.

A 2021 systematic review covering 17 original studies found that vaginal and vulvar HA was generally associated with improvements in symptoms including dryness, itching, burning and dyspareunia, as well as several objective vaginal-health parameters. citeturn0search8

More recently, the 2026 systematic review and meta-analysis strengthened the evidence base by analyzing randomized controlled trials in postmenopausal women. Eleven studies met its inclusion criteria, and the analysis reported favorable outcomes for vaginal dryness-related quality of life and sexual function, while highlighting heterogeneity between studies and the importance of better-standardized formulations and protocols. 

The future opportunity may not simply be to use HA, but to better understand and optimize the HA being used.

Molecular-weight selection, concentration, excipients and delivery technology may all contribute to how the next generation of vaginal HA products is differentiated.

A Non-Hormonal Opportunity in Women’s Health

Demand for effective non-hormonal approaches to vaginal dryness continues to create opportunities for women’s health brands.

HA is particularly interesting because it combines a well-recognized ingredient with an expanding body of vaginal-health research and considerable room for formulation innovation.

For brands, this opens the possibility of moving beyond conventional moisturizing concepts toward science-driven vaginal delivery systems designed around the characteristics of the vaginal environment itself.

And molecular weight may become an increasingly important part of that conversation.

Looking for your next vaginal health innovation?

Talk to Hudi Pharma about hyaluronic acid and next-generation vaginal delivery solutions.

FDA References

• • Dahab M, Ramasamy K, Ibrahim B. Hyaluronic acid for vaginal health and quality of life in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials. International Journal of Gynecology & Obstetrics. 2026;174(2):643–654.

  • Dos Santos CCM, et al. Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review. Climacteric. 2021.

  • Grimaldi EF, et al. Role of high molecular weight hyaluronic acid in postmenopausal vaginal discomfort. Minerva Ginecologica. 2012;64(4):321–329.

  • Hyaluronic Acid in Female Reproductive Health: Tailoring Molecular Weight to Clinical Needs in Obstetric and Gynecological Fields. Pharmaceutics. 2025;17(8):991.